BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Robert Kirsner, MD, PhD, to Present Results for Phase 2b 6-Month Follow-Up Trial of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers

  July 25, 2012

   · 

  5 min read
• Business

  Neogen Corporation Reports Year End Results

  July 25, 2012

   · 

  6 min read
• FDA

  Qualitest Pharmaceuticals Receives FDA Approval for Levetiracetam Extended-Release Tablets, 500mg and 750mg

  July 25, 2012

   · 

  1 min read
• Business

  SYGNIS Pharma AG Reports Financial Results for Fiscal Year 2011/2012

  July 25, 2012

   · 

  4 min read
• Drug Development

  CytRx Corporation Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin (INNO-206) and Doxorubicin in Patients with Advanced Solid Tumors

  July 25, 2012

   · 

  1 min read
• Business

  Isconova Concludes Partnership With Virbac S.A.

  July 25, 2012

   · 

  1 min read
• Business

  Stentys Revenues for the First Half of 2012 Increase 92% over Prior Year

  July 25, 2012

   · 

  1 min read
• Business

  BioFocus DPI Expands Its Drug Discovery Offering With Proteomics Technology From Activiomics

  July 25, 2012

   · 

  1 min read
• Pharm Country

  New and Revised IEEE 11073(TM) Standards Expand Support for Plug-and-Play, Interoperable Medical-Device Communications

  July 25, 2012

   · 

  1 min read
• Policy

  Gilead Sciences, Inc. HIV Drug as Good as Merck & Co., Inc.'s Isentress

  July 25, 2012

   · 

  1 min read